Sally A Arif

Summary

Affiliation: Midwestern University
Country: USA

Publications

  1. doi request reprint Vorapaxar for reduction of thrombotic cardiovascular events in myocardial infarction and peripheral artery disease
    Sally A Arif
    Sally A Arif, Pharm D, BCPS AQ Cardiology, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, and clinical pharmacist, Department of Pharmacy, Rush University Medical Center, Chicago, IL Jennifer D Souza, Pharm D, CDE, BC ADM, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University Monika Gil, Pharm D, BCPS, is Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center Suzanna Gim, B A, Pharm D, M P H, is Associate Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Drug Information Specialist, Brookdale University Hospital and Medical Center, Brooklyn
    Am J Health Syst Pharm 72:1615-22. 2015
  2. pmc Journal clubs during advanced pharmacy practice experiences to teach literature-evaluation skills
    Sally A Arif
    Chicago College of Pharmacy, Midwestern University, Downers Grove, IL 60515, USA
    Am J Pharm Educ 76:88. 2012
  3. doi request reprint Treatment of systolic heart failure in the elderly: an evidence-based review
    Sally A Arif
    Midwestern University, Downers Grove, IL, USA
    Ann Pharmacother 44:1604-14. 2010
  4. doi request reprint Iloperidone: A new drug for the treatment of schizophrenia
    Sally A Arif
    Chicago College of Pharmacy, Midwestern University, Downers Grove, IL 60515, USA
    Am J Health Syst Pharm 68:301-8. 2011
  5. doi request reprint Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension
    Sally A Arif
    Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois, USA
    Clin Ther 33:993-1004. 2011

Detail Information

Publications5

  1. doi request reprint Vorapaxar for reduction of thrombotic cardiovascular events in myocardial infarction and peripheral artery disease
    Sally A Arif
    Sally A Arif, Pharm D, BCPS AQ Cardiology, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, IL, and clinical pharmacist, Department of Pharmacy, Rush University Medical Center, Chicago, IL Jennifer D Souza, Pharm D, CDE, BC ADM, is Associate Professor of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University Monika Gil, Pharm D, BCPS, is Clinical Pharmacist, Department of Pharmacy, Rush University Medical Center Suzanna Gim, B A, Pharm D, M P H, is Associate Professor of Pharmacy Practice, Arnold and Marie Schwartz College of Pharmacy and Health Sciences, Long Island University, Brooklyn, NY, and Drug Information Specialist, Brookdale University Hospital and Medical Center, Brooklyn
    Am J Health Syst Pharm 72:1615-22. 2015
    ..The pharmacology, pharmacokinetics, clinical efficacy, adverse effects, dosage and administration, cost, and place in therapy of vorapaxar in the secondary prevention of atherosclerotic events are reviewed...
  2. pmc Journal clubs during advanced pharmacy practice experiences to teach literature-evaluation skills
    Sally A Arif
    Chicago College of Pharmacy, Midwestern University, Downers Grove, IL 60515, USA
    Am J Pharm Educ 76:88. 2012
    ..To determine pharmacy students' attitudes and academic performance related to journal club during 2 advanced pharmacy practice experiences (APPEs)...
  3. doi request reprint Treatment of systolic heart failure in the elderly: an evidence-based review
    Sally A Arif
    Midwestern University, Downers Grove, IL, USA
    Ann Pharmacother 44:1604-14. 2010
    ....
  4. doi request reprint Iloperidone: A new drug for the treatment of schizophrenia
    Sally A Arif
    Chicago College of Pharmacy, Midwestern University, Downers Grove, IL 60515, USA
    Am J Health Syst Pharm 68:301-8. 2011
    ..The pharmacology, pharmacokinetics, pharmacogenomics, clinical efficacy, and safety and tolerability profile of iloperidone for the treatment of schizophrenia are reviewed...
  5. doi request reprint Tadalafil: a long-acting phosphodiesterase-5 inhibitor for the treatment of pulmonary arterial hypertension
    Sally A Arif
    Department of Pharmacy Practice, Chicago College of Pharmacy, Midwestern University, Downers Grove, Illinois, USA
    Clin Ther 33:993-1004. 2011
    ..Tadalafil is a phosphodiesterase-5 (PDE-5) inhibitor that was approved by the US Food and Drug Administration (FDA) in 2009 for the treatment of pulmonary arterial hypertension (PAH)...